Coronavirus Notebook: Gavi Vaccines Move Under Fire, EU-US Step Up Regulatory Cooperation
Executive Summary
In this latest Coronavirus Notebook, an international vaccine incentive mechanism comes under attack, researchers look at how to solve cold-chain coronavirus distribution problems in Africa, and Sanofi invests in a “world reference” vaccines R&D facility.
You may also be interested in...
Coronavirus Notebook: Dexamethasone Reduces Deaths In Hospitalized COVID-19 Patients
The standout development in this latest Coronavirus Notebook is that the cheap and plentiful steroid dexamethasone has been shown to reduce deaths by a third in ventilated COVID-19 patients in the UK Recovery trial. In other news, there is fresh funding for smaller firms working on potential treatments and vaccines, and a number of organizations have decided to make their research tools and resources available free of charge in return for open publication of any coronavirus-related findings.
New Gavi Fund To Guarantee Global Market For COVID-19 Vaccines
The latest global vaccines summit has seen the launch of a new mechanism designed to spur the development of new coronavirus vaccines and ensure they are made available, particularly in low- and middle-income countries.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.